Michael J. Ray's  Instablog

Michael J. Ray
Send Message
An investor who watches and tracks trends and uses options to hedge the risk. I run a balanced portfolio which contains both growth and income related securities.
  • An Investment in KERX 0 comments
    May 17, 2011 11:07 AM | about stocks: KERX
    http://www.examiner.com/stock-market-in-albuquerque/an-investment-kerx".....A second product the company is working on is Perifosine which is an oral anti-cancer drug.  For the science folks out there, it inhibits Akt activation in the phosphoinositide pathway.  For the common person that basically means that the drug attempts to stop the growth of the cancer and might even shrink it.  Keryx has the drug on license from another company.   In September 2002, the company entered a commercial license agreement with Zentaris AG, a wholly-owned subsidiary of AEterna Zentaris Inc.  This agreement granted exclusive rights to Perifosine in the U.S., Canada, and Mexico.  At the current time 2,000 patients in the US and Europe have been involved with the trials of this new drug.  So far the safety tests have done very well.  Side effects have been much less severe as compared to other medicines that are currently used to treat this illness.


    If both products were to be accepted by the FDA then the valuation of the stock price would be much higher than it is today.  Trying to come up with a more specific number is just not possible at this point in time.  Often times companies like this get bought out pretty quickly.  If not then the company will often time have secondary offerings to raise funds to cover the costs of ramping up.  So trying to come up with a good number is almost impossible.  Currently the stock trades around $5 and seems to be held in place by the option dealers who make money by using calls and puts to generate cash.  As the stock moves closer to its final date with the FDA approval process though, one will find it break those chains and move up in value rather quickly."

    Stocks: KERX
Back To Michael J. Ray's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.